PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F16BH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $227,135
Award facts
- Contract value 100% obligated
- $227,134.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $227,134.72 by the Defense Logistics Agency's Medical Supply Chain on January 31, 2026, with an ultimate completion date of February 2, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the company's substantial role in federal pharmaceutical procurement. The award falls under Amerisourcebergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling delivery of a vast range of pharmaceutical products, medical supplies, vaccines, and specialized medical commodities across multiple therapeutic domains to support military healthcare programs worldwide.
Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), which holds the parent IDC with DLA valued at up to $999,999,999.00 through December 31, 2031. The Defense Logistics Agency's Troop Support Medical division utilizes these contracts to ensure reliable supply of critical pharmaceutical and medical commodities to Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Amerisourcebergen's consistent success in winning competitive awards across multiple therapeutic domains—including specialty medications, brand-name and generic drugs, diabetes treatments, neurological medications, and pain management pharmaceuticals—reflects the company's established capability to meet complex federal medical supply requirements efficiently and at firm fixed prices.
Quick answers
Who was awarded contract SPE2D826F16BH?
SPE2D826F16BH was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 31, 2026.
How much is contract SPE2D826F16BH worth?
The government has obligated $227,135 on SPE2D826F16BH.
Is contract SPE2D826F16BH an order under another contract?
Yes. SPE2D826F16BH is a delivery order under SPE2DX22D0020, an indefinite delivery contract.
Was contract SPE2D826F16BH competed?
The extent of competition for SPE2D826F16BH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award